129 related articles for article (PubMed ID: 15464247)
1. Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.
Mueller T; Mas-Marques A; Sarrazin C; Wiese M; Halangk J; Witt H; Ahlenstiel G; Spengler U; Goebel U; Wiedenmann B; Schreier E; Berg T
J Hepatol; 2004 Oct; 41(4):652-8. PubMed ID: 15464247
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the IL-12B gene and outcome of HCV infection.
Houldsworth A; Metzner M; Rossol S; Shaw S; Kaminski E; Demaine AG; Cramp ME
J Interferon Cytokine Res; 2005 May; 25(5):271-6. PubMed ID: 15871664
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection.
Mas Marques A; Mueller T; Welke J; Taube S; Sarrazin C; Wiese M; Halangk J; Witt H; Ahlenstiel G; Spengler U; Goebel U; Schott E; Weich V; Schlosser B; Wasmuth HE; Lammert F; Berg T; Schreier E
Infect Genet Evol; 2009 Sep; 9(5):847-52. PubMed ID: 19446659
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.
Rosen HR; McHutchison JG; Conrad AJ; Lentz JJ; Marousek G; Rose SL; Zaman A; Taylor K; Chou S
Am J Gastroenterol; 2002 Mar; 97(3):714-20. PubMed ID: 11922568
[TBL] [Abstract][Full Text] [Related]
6. Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3.
Suneetha PV; Goyal A; Hissar SS; Sarin SK
J Med Virol; 2006 Aug; 78(8):1055-60. PubMed ID: 16789008
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus.
Sánchez E; Morales S; Paco L; López-Nevot MA; Hidalgo C; Jiménez-Alonso J; Torres B; González-Gay MA; Callejas JL; Ortego-Centeno N; Sánchez-Roman J; González-Escribano MF; Martín J
Rheumatology (Oxford); 2005 Sep; 44(9):1136-9. PubMed ID: 15941730
[TBL] [Abstract][Full Text] [Related]
8. Associations of the IL12B promoter polymorphism in longitudinal data from asthmatic patients 7 to 42 years of age.
Khoo SK; Hayden CM; Roberts M; Horak E; de Klerk N; Zhang G; Robertson CF; Goldblatt J; Le Souëf P
J Allergy Clin Immunol; 2004 Mar; 113(3):475-81. PubMed ID: 15007350
[TBL] [Abstract][Full Text] [Related]
9. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
10. The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.
Nattermann J; Vogel M; Nischalke HD; Danta M; Ahlenstiel G; Michalk M; Sauerbruch T; Rockstroh JK; Spengler U;
AIDS; 2008 Jul; 22(11):1287-92. PubMed ID: 18580607
[TBL] [Abstract][Full Text] [Related]
11. Association of functional polymorphism of ApoB promoter with hepatitis C virus infection.
Zhu C; Zhang R; Liu D; Mukhtar MM; Liu W; Peng G; Wang K; Hao Q; Xu Y; Liu F; Zhu Y; Wu J
Clin Chim Acta; 2009 Mar; 401(1-2):124-7. PubMed ID: 19083997
[TBL] [Abstract][Full Text] [Related]
12. Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C.
Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Gartung C; Lorenzen J; Matern S; Lammert F
Hepatology; 2004 Aug; 40(2):327-34. PubMed ID: 15368437
[TBL] [Abstract][Full Text] [Related]
13. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis.
Orozco G; González-Gay MA; Paco L; López-Nevot MA; Guzmán M; Pascual-Salcedo D; Balsa A; Martín J
Hum Immunol; 2005 Jun; 66(6):710-5. PubMed ID: 15993716
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Hsieh MY; Hou NJ; Lin ZY; Huang JF; Hsieh MY; Wang LY; Yu ML
J Infect Dis; 2006 Jan; 193(1):98-101. PubMed ID: 16323137
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
[TBL] [Abstract][Full Text] [Related]
17. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
Bouzgarrou N; Hassen E; Schvoerer E; Stoll-Keller F; Bahri O; Gabbouj S; Cheikh I; Maamouri N; Mammi N; Saffar H; Trabelsi A; Triki H; Chouchane L
J Med Virol; 2008 Apr; 80(4):607-14. PubMed ID: 18297714
[TBL] [Abstract][Full Text] [Related]
19. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
Aguilar-Reina J; Ruiz-Ferrer M; Pizarro MA; Antiñolo G
J Viral Hepat; 2005 Nov; 12(6):568-73. PubMed ID: 16255757
[TBL] [Abstract][Full Text] [Related]
20. Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes.
Windsor L; Morahan G; Huang D; McCann V; Jones T; James I; Christiansen FT; Price P
Hum Immunol; 2004 Dec; 65(12):1432-6. PubMed ID: 15603869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
